Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.1343
-0.0007 (-0.52%)
Aug 12, 2026, 12:08 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 9.19 million as of August 12, 2026. Its market cap has decreased by -54.85% in one year.
Market Cap
9.19M
Enterprise Value
7.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 9.19M, a decrease of -60.10%. That is a compound annual growth rate of -18.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 9.19M | -56.45% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 17.44M |
| Aptamer Group | 15.55M |
| Fusion Antibodies | 13.44M |
| Genflow Biosciences | 11.61M |
| Palatin Technologies | 10.39M |
| Cizzle Biotechnology Holdings | 7.22M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.62M |